Navigation Links
Presentations at Leading Radiation Oncology Meeting Highlight CyberKnife Prostate Outcomes from Patients at More Than 40 Centers
Date:11/5/2012

botics, we're able to continuously track the prostate and concentrate hundreds of radiation beams into the target with sub-millimeter accuracy, which helps us effectively treat the disease while sparing nearby healthy tissue and critical structures."

Donald Fuller, M.D., a radiation oncologist from Genesis Healthcare in San Diego, presented findings from a multi-center study of 260 patients with low and intermediate-risk prostate cancer treated using CyberKnife SBRT at 17 institutions, using an approach that emulates the dosimetry of high dose rate (HDR) brachytherapy.

Patients were followed for up to 48 months with a median follow-up of 24 months, and found to have disease-free survival of 98.5 percent, as updated during his presentation. Urinary and rectal toxicities reported at a minimum 1 year follow-up were in line with outcomes of traditional radiation therapy and erectile function returned to baseline by 3 years, with minimal disruption after treatment.

"These findings should encourage men to explore CyberKnife SBRT as a viable alternative to surgery or other radiation treatments, such as brachytherapy and intensity-modulated radiation therapy," said Dr. Fuller. "Findings to date indicate we may be able to minimize the undesirable side effects typically associated with other treatment modalities and help to preserve patients' quality of life during and after prostate cancer treatment."

Additionally, seven posters highlighting CyberKnife prostate SBRT experience were presented by researchers from the University of California San Francisco, Georgetown University Hospital, and Winthrop University Hospital, as well as additional research from Flushing Radiation Oncology and Swedish Cancer Institute in Seattle, further supporting the maturing body of prostate SBRT evidence.

About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale
'/>"/>

SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Thoratec Announces Presentations At Upcoming Investor Conferences
2. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
3. Regeneron Announces September 2012 Investor Conference Presentations
4. Cynosure Announces Upcoming Conference Presentations
5. InterMune Announces Presentations of New Research in IPF at ERS
6. Cepheid to Webcast Upcoming Financial Presentations
7. Regeneron Announces June 2012 Investor Conference Presentations
8. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
9. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
10. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
11. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... NEW YORK , May 6, 2015 /PRNewswire/ ... patient activation and patient-reported outcomes for chronic pain, ... report released by The Bravewell Collaborative ... by the Patients Receiving Integrative Medicine Interventions Effectiveness ... medicine. Using data from PRIMIER ...
(Date:5/6/2015)... May 6, 2015 Saint-Gobain has ... manufacture of filtration products, mainly for the life sciences ... filters manufactured in a state-of-the-art plant in ... sold across the globe and will bolster the range ... This acquisition is fully in line with the ...
(Date:5/6/2015)... 2015 Fibich, Leebron, Copeland, Briggs & Josephson ... has been reached to resolve lawsuits involving individuals who ... Actos - manufactured by Takeda Pharmaceuticals - has been ... Several of the firm,s attorneys were instrumental in the ... Tommy Fibich - Founding Partner of Fibich, Leebron, ...
Breaking Medicine Technology:Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression 2Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2
... Ontario, May 15, 2012 LifeLearn, Inc. announced ... Distinction for multimedia educational programs that the company ... and Novartis Animal Health (Novartis) during 2011. These ... teach scientific principles to healthcare staff. ...
... May 15, 2012 Reportlinker.com ... research report is available in ... Global ... Marketing Spend and Sales Strategies ...
Cached Medicine Technology:LifeLearn wins awards for three multimedia education programs 2Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 2Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 3Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 4Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 5Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 6Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 7Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 8Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 9Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 10Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 11Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 12Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 13Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 14Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 15Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 16Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 17Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry 18
(Date:5/6/2015)... Miami, FL (PRWEB) May 06, 2015 Qushanna ... baby outside a nearby drug treatment center in Florida while ... on May 4th. New surveillance tapes released by CBS4’s ... 7am, without her baby. Doby’s child is around one year ... baby crying and shivering outside was not named. The residents ...
(Date:5/6/2015)... 06, 2015 Prime Pacific Health ... excited to announce a new series of universal, ... industry’s carbon footprint while improving treatment efficacy and ... Eco-Flex™, the world’s first waste hose designed ... for hydrotherapists,” claims the company’s president, Mr. Delmar ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 “ SideChef ” was ... a look at the latest and coolest applications on the market ... and technology expert, conducted the app review and shared with viewers ... in the day when to be a good navigator people had ... out and now everyone is a master navigator. Well what if ...
(Date:5/6/2015)... May 06, 2015 vcfo, a specialized ... IT and operational support to optimize business performance and ... Jack Lynch and Michael Scheaffer. Both Lynch and Scheaffer ... leadership experience. , “We are delighted to add ... vcfo CEO. “Leveraging their background in financial management and ...
(Date:5/6/2015)... TX (PRWEB) May 06, 2015 ... 1,000 user mark after launching in mid-February. The company ... candidates who have previous experience in the industry. Likewise, ... profession. , According to Kyle Johnson, CTO, unique traffic ... to the first month: "Each new job posting brings ...
Breaking Medicine News(10 mins):Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2
... An overactive BAALC gene in acute leukemia cells identifies ... therapy. This study discovered why the gene is often ... help guide therapy in these patients. COLUMBUS, Ohio ... for overactivating a gene linked to poor treatment response in ...
... should be a standard practice of care for pediatric ... growth status and improve treatment, according to a new ... "Not only is bone age helpful in predicting ... bone age is necessary to correctly interpret a patient,s ...
... System has launched the UCLA Face Transplantation Program, the first ... and one of only a handful in the nation. ... to persons who have suffered the devastating loss of their ... associate professor of surgery at the David Geffen School of ...
... work in mice suggested that the immune system is involved ... Researchers have now shown for the first time that this ... College of Medicine and Dentistry, University of Exeter with colleagues ... in Italy screened the expression levels of thousands of genes ...
... Goodwin HealthDay Reporter , THURSDAY, May 24 ... before age 3, most children with autism are diagnosed ... autism in America shows. More than half of ... at least one psychotropic medicine -- including stimulants, anti-anxiety ...
... Reporter , THURSDAY, May 24 (HealthDay News) -- Preeclampsia, a ... predispose offspring to high blood pressure in childhood and young ... life, these children have distinct cardiovascular risk factors that may ... British researchers said. "A pregnancy complicated by preeclampsia is ...
Cached Medicine News:Health News:Inherited DNA change explains overactive leukemia gene 2Health News:Routine care for Crohn's disease in children should include measurement of bone age 2Health News:Routine care for Crohn's disease in children should include measurement of bone age 3Health News:UCLA launches first face transplantation program in western US 2Health News:UCLA launches first face transplantation program in western US 3Health News:Autism Often Not Diagnosed Until Age 5 or Older: U.S. Report 2Health News:Autism Often Not Diagnosed Until Age 5 or Older: U.S. Report 3Health News:High Blood Pressure in Pregnancy May Threaten Kids' Heart Health 2Health News:High Blood Pressure in Pregnancy May Threaten Kids' Heart Health 3
... OCUFLOX® ophthalmic solution is an ... your doctor may instruct you ... an eye infection caused by ... ulcers are the 2 types ...
...
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is medication in the form of an eye drop that is used to lower the pressure inside your eye(s), also referred to as intraocular pressu...
Medicine Products: